PGNY Stock Analysis: Buy, Sell, or Hold?
PGNY - Progyny, Inc. Common Stock
$25.45
-0.20 (-0.78%)
▼
5d:
+0.47%
30d:
-18.4%
90d:
+2.29%
HOLD
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When PGNY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PGNY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: PGNY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$37.19
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$23.09
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PGNY is currently trading at $25.45, which is considered oversold relative to its 30-day fair value range of $26.45 to $31.81. The stock's valuation (Forward PE: 11.3) is in line with its historical norms (11.4). Remarkably, the market is currently pricing in an annual earnings decline of 0.2% over the next few years. This pessimistic expectation contrasts with the company's recent 78.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PGNY is in a strong uptrend. The price is currently testing key support at $25.24. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PGNY scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $33.73 (+29.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PGNY is in a strong uptrend. The price is currently testing key support at $25.24. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PGNY scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $33.73 (+29.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$26.45 -
$31.81
Company Quality Score
66/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
92.3%
Protect Your Profits
Holding PGNY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 29.9% below Wall St target ($33.73)
- CAUTION: Bottoming setup, but lagging the sector by 19% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$26.45 -
$31.81
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.50
(5.9%)
Support & Resistance Levels
Support Level
$25.24
Resistance Level
$28.23
Current Trend
Strong Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.28
Wall Street Target
$33.73
(+29.9%)
Revenue Growth (YoY)
5.3%
Earnings Growth (YoY)
78.9%
Profit Margin
6.0%
Valuation Discount vs History
-0.2% cheaper
PE vs Historical
11.3 vs 11.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.2%
(market-implied from PE analysis)
1-Year Target
$25.91
(0%)
2-Year Target
$25.86
(0%)
3-Year Target
$25.80
(-1%)
3-Yr Target (if PE normalizes)
(PE: 11→11)
$26.08
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 10.5%)
$62.27
(+140%)
Base:
(SPY PE: 11.3, Growth: 10.5%)
$35.00
(+35%)
Bear:
(PE: 9.6, Growth: 10.5%)
$29.75
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (28x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 27.95 | Current EPS (TTM): $0.92
Bull Case
$56.56
(+122%)
Analyst growth 100.0%, PE expands to 30.7
Base Case
$51.42
(+102%)
Market implied 100.0%, PE stable at 28.0
Bear Case
$17.48
(-31%)
Severe decline -20.0%, PE contracts to 23.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.3 to 11.4
Stabilization Target:
$26.24
(+1.1%)
PE Expansion Potential:
+1.1%
Share & Embed Analysis
Last updated: August 24, 2026 9:48 PM ET
Data refreshes hourly during market hours. Next update: 10:48 PM
Data refreshes hourly during market hours. Next update: 10:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PGNY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Allison Swartz
SELL
599 shares
2026-03-04
Allison Swartz
SELL
4657 shares
2026-03-03
Allison Swartz
SELL
2199 shares
2026-03-02
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$116 | 59 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$475 | 61 BUY |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 58 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$449 | 57 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$416 | 60 BUY |
Advanced PGNY Option Strategies
Professional options setups generated by AI based on today's PGNY price and gamma walls.
